NSU Newsroom
SharkBytes
Horizons
This version of NSU News has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of NSU News, visit news.nova.edu.
This version of SharkBytes has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of SharkBytes, visit sharkbytes.nova.edu.
NSU Researcher Invents Sublingual Epinephrine Tablet to Replace EpiPen
Multiple Media Outlets Covered Story on New Creation
Mutasem Rawas-Qalaji, B. Pharm. (Hon.), Ph.D., NSU pharmaceutical researcher
The debate over the expense associated with EpiPens® may be coming to a halt, thanks to pharmaceutical researcher and Associate Professor at NSU’s College of Pharmacy Mutasem Rawas-Qalaji, B. Pharm. (Hon.), Ph.D.
Several media outlets featured Rawas-Qalaji’s new oral method for patients to receive epinephrine. Generally, the benefits of the drug aren’t seen when ingested, which is why most patients carry around the pen; however, Rawas-Qalaji developed a tablet that will allow the drug to work quickly and effectively.
- Click HERE to read an article on CNBC.
- Click HERE to read an article in Popular Science.
- Click HERE to read an article in Digital Trends.
- Click HERE to view story on WPLG – Ch. 10 Miami